Pearson's marrow/pancreas syndrome

Pearson's marrow/pancreas syndrome is a rare genetic disorder characterized by bone marrow failure and pancreas dysfunction. It is a multisystem disorder that primarily affects the hematologic and exocrine pancreatic systems, but can also impact other organs and systems within the body. The syndrome was first described by Howard Pearson et al. in 1979, following the observation of a distinct set of clinical features in affected individuals.

Causes

Pearson's marrow/pancreas syndrome is caused by deletions or rearrangements in the mitochondrial DNA (mtDNA). These genetic alterations lead to mitochondrial dysfunction, which is central to the pathogenesis of the syndrome. Mitochondria are crucial for energy production in cells, and their dysfunction can affect multiple organ systems, particularly those with high energy demands such as the bone marrow and pancreas.

Symptoms

The clinical presentation of Pearson's marrow/pancreas syndrome can vary significantly among affected individuals. However, common symptoms include:

• Sideroblastic anemia - a form of anemia characterized by the presence of ringed sideroblasts in the bone marrow
• Pancytopenia - a reduction in the number of red and white blood cells, as well as platelets
• Exocrine pancreatic dysfunction leading to malabsorption and failure to thrive in infants
• Diabetes mellitus due to endocrine pancreatic insufficiency
• Liver dysfunction
• Renal tubulopathy

Diagnosis

Diagnosis of Pearson's marrow/pancreas syndrome is based on clinical presentation, laboratory findings, and genetic testing. Key diagnostic tests include:

• Complete blood count (CBC) with differential to assess for anemia and pancytopenia
• Bone marrow biopsy to identify ringed sideroblasts and other abnormalities
• Genetic testing for deletions or rearrangements in mitochondrial DNA

Treatment

There is no cure for Pearson's marrow/pancreas syndrome, and treatment is supportive and symptomatic. Management strategies may include:

• Regular blood transfusions to manage anemia
• Pancreatic enzyme supplements to aid in digestion and nutrient absorption
• Insulin therapy for diabetes
• Possible bone marrow transplantation in cases with severe bone marrow failure

Prognosis

The prognosis for individuals with Pearson's marrow/pancreas syndrome varies depending on the severity of symptoms and the extent of organ involvement. Early diagnosis and management of symptoms can improve quality of life, but the disorder can be life-threatening, particularly in cases with severe bone marrow failure.

See also

• Mitochondrial disease
• Sideroblastic anemia
• Pancytopenia

Pearson's marrow/pancreas syndrome Resources
Latest articles Most recent articles Ongoing trials	Wikipedia